Glenmark Pharma reports consolidated revenue growth of 6.3% and adjusted EBITDA growth of 8.3% YoY for Q2 FY 2023-24

Glenmark Pharma reports consolidated revenue growth of 6.3% and adjusted EBITDA growth of 8.3% YoY for Q2 FY 2023-24

Source link : https://www.prnewswire.com/in/news-releases/glenmark-pharma-reports-consolidated-revenue-growth-of-6-3-and-adjusted-ebitda-growth-of-8-3-yoy-for-q2-fy-2023-24–301984824.html

Author :

Publish date : 2023-11-10 08:00:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version